IQVIA (NYSE:IQV) is a leading global provider of advanced analytics, technology solutions and contract research services to the life sciences industry. Formed through the merger of IMS Health and Quintiles, IQVIA applies human data science — leveraging the analytic rigor and clarity of data science to the ever-expanding scope of human science — to enable companies to reimagine and develop new approaches to clinical development and commercialization, speed innovation and accelerate improvements in healthcare outcomes. Powered by the IQVIA CORE™, IQVIA delivers unique and actionable insights at the intersection of large-scale analytics, transformative technology and extensive domain expertise, as well as execution capabilities. With more than 58,000 employees, IQVIA conducts operations in more than 100 countries.
IQVIA is a global leader in protecting individual patient privacy. The company uses a wide variety of privacy-enhancing technologies and safeguards to protect individual privacy while generating and analyzing information on a scale that helps healthcare stakeholders identify disease patterns and correlate with the precise treatment path and therapy needed for better outcomes. IQVIA’s insights and execution capabilities help biotech, medical device and pharmaceutical companies, medical researchers, government agencies, payers and other healthcare stakeholders tap into a deeper understanding of diseases, human behaviors and scientific advances, in an effort to advance their path toward cures.
Origins is a health experience research company, driven by curiosity. We uncover how and why people interact in different ways with their condition and treatment. We aim to give these audiences a voice through novel ethnographic methodologies that can inform future communications.
As part of the independent Bedrock Group, Origins works alongside the award-winning communications team, to provide the insights for medical communication and education programmes. Jeremy Sayers heads up the Origins team that is packed with research expertise across audiences and methodologies.
Patient Connect utilises a global network of health care professionals, supporting patients throughout the care pathway, and delivering actionable clinical insights to biopharmaceutical companies, empowering them to make informed decisions and take a more patient centric approach.
Our innovative digital messaging services disrupt patterns of poor medication adherence and sub-s optimal care, and have measurable clinical and commercial outcomes. While our patient level data gathered at the point of care provides unmatched insight and clarity.
We highlight key areas of improvement, deliver the solution, and measure the outcomes with reach to 300,000 pharmacists and 493,500 physicians giving us access to 400m patients. We engage our patients and healthcare professionals using digital messaging, electronic forms, printed leaflets, letters and SMS alerts.
Within3 is the leading software communications company for life science and healthcare organizations. Our online discussion platform allows organizations to compliantly engage small or large groups of physicians, nurses, payers, and patients.
Within3 is proud to partner with 18 of the top 20 pharmaceutical companies, as well as leading medical organizations and agencies, in over 150 countries. Rely on us to communicate safely, compliantly, and seamlessly with external stakeholders — including physicians, patients, allied health professionals, payers, researchers, consumer businesses, coalitions, and healthcare executives.
When engagement matters, companies choose Within3.